David J. Ecker
Founder at Ibis Biosciences LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Brett Monia | M | 62 | 35 years | |
| Patrick O'Neil | M | 50 | 23 years | |
| Kenneth N. Raymond | M | - |
Lumiphore, Inc.
 Lumiphore, Inc. BiotechnologyHealth Technology Lumiphore, Inc. develops proprietary bi-functional chelators for biomedical applications in drug discovery research, diagnostics, and therapeutics. The firm offers biological detection systems based on luminescent lanthanide complexes and radioisotope chelators for attachment to carrier molecules used in cancer therapeutics and radio-imaging diagnostics that can be paired as a companion diagnostics in radio-pharmaceutical therapeutics. The company was founded by Stephane Petoud and Kenneth N. Raymond in 2001 and is headquartered in Berkeley, CA. | 23 years |
| B. Parshall | F | 70 | 33 years | |
| Elizabeth Hougen | F | 62 | 24 years | |
| John A. McNeil | M | 59 |
Ibis Biosciences LLC
 Ibis Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Ibis Biosciences develops systems for identification and characterization of infectious agents. It offers Ibis T5000 Biosensor System, a hardware platform for the identification of biological organisms including bacteria, viruses, fungi, and protozoa. The company was founded by David J. Ecker and is headquartered in Abbott Park, IL. | 25 years |
| Nathaniel G. Butlin | M | - |
Lumiphore, Inc.
Lumiphore, Inc. BiotechnologyHealth Technology Lumiphore, Inc. develops proprietary bi-functional chelators for biomedical applications in drug discovery research, diagnostics, and therapeutics. The firm offers biological detection systems based on luminescent lanthanide complexes and radioisotope chelators for attachment to carrier molecules used in cancer therapeutics and radio-imaging diagnostics that can be paired as a companion diagnostics in radio-pharmaceutical therapeutics. The company was founded by Stephane Petoud and Kenneth N. Raymond in 2001 and is headquartered in Berkeley, CA. | - |
| Spencer Berthelsen | M | 71 | 22 years | |
| C. Bennett | M | 67 | 35 years | |
| Joseph Wender | M | 79 | 30 years | |
| Joseph Klein | M | 62 | 19 years | |
| Stephen H. Blose | M | - |
Lumiphore, Inc.
Lumiphore, Inc. BiotechnologyHealth Technology Lumiphore, Inc. develops proprietary bi-functional chelators for biomedical applications in drug discovery research, diagnostics, and therapeutics. The firm offers biological detection systems based on luminescent lanthanide complexes and radioisotope chelators for attachment to carrier molecules used in cancer therapeutics and radio-imaging diagnostics that can be paired as a companion diagnostics in radio-pharmaceutical therapeutics. The company was founded by Stephane Petoud and Kenneth N. Raymond in 2001 and is headquartered in Berkeley, CA. | - |
| Sanjay Bhanot | M | - | 24 years | |
| Norbert Neef | M | 57 |
Lumiphore, Inc.
Lumiphore, Inc. BiotechnologyHealth Technology Lumiphore, Inc. develops proprietary bi-functional chelators for biomedical applications in drug discovery research, diagnostics, and therapeutics. The firm offers biological detection systems based on luminescent lanthanide complexes and radioisotope chelators for attachment to carrier molecules used in cancer therapeutics and radio-imaging diagnostics that can be paired as a companion diagnostics in radio-pharmaceutical therapeutics. The company was founded by Stephane Petoud and Kenneth N. Raymond in 2001 and is headquartered in Berkeley, CA. | - |
| Darren Magda | M | - |
Lumiphore, Inc.
Lumiphore, Inc. BiotechnologyHealth Technology Lumiphore, Inc. develops proprietary bi-functional chelators for biomedical applications in drug discovery research, diagnostics, and therapeutics. The firm offers biological detection systems based on luminescent lanthanide complexes and radioisotope chelators for attachment to carrier molecules used in cancer therapeutics and radio-imaging diagnostics that can be paired as a companion diagnostics in radio-pharmaceutical therapeutics. The company was founded by Stephane Petoud and Kenneth N. Raymond in 2001 and is headquartered in Berkeley, CA. | - |
| Richard Geary | M | 66 | 29 years | |
| Eric Swayze | M | - | 30 years | |
| Matt Buck | M | - | 19 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stanley Crooke | M | 78 |
Smithkline & French Laboratories US, Inc.
| 41 years |
| Chris Mirabelli | M | 69 | 4 years | |
| John Reed | M | 65 | 11 years | |
| Joshua Patterson | M | 48 | 12 years | |
| Frederick Muto | M | 70 | 21 years | |
| Dan Kisner | M | 77 | 8 years | |
| Susan Knudson | F | 60 | - | |
| Jennifer Giottonini Cayer | F | - | 1 years | |
| Jeffrey Black | M | 55 | 2 years | |
| Gary J. G. Atkinson | M | 71 | 5 years | |
| Muthiah Manoharan | M | - | 13 years | |
| Jon T. Holmlund | M | 67 | 7 years | |
| Dean Taylor | M | - |
Smithkline & French Laboratories US, Inc.
| 10 years |
| Edgardo Baracchini | M | 64 | 4 years | |
| Nicholas M. Dean | M | 66 | - | |
| Thomas Malefyt | M | - |
Smithkline & French Laboratories US, Inc.
| - |
| Ethel M. Koczon | F | - | 5 years | |
| Karen Potts | M | 61 | 3 years | |
| Neil Abdollahian | M | 51 | 1 years | |
| Daniel Ripley | M | 63 | 6 years | |
| Joseph Johnston | M | - | 26 years | |
| David Slack | M | 61 | 4 years | |
| Brian Dickson | M | - |
Smithkline & French Laboratories US, Inc.
| 9 years |
| Lisa R. Grillone | M | 74 | 10 years | |
| Yasunori Kaneko | M | 69 | 1 years | |
| Richard DiMarchi | M | 71 | 7 years | |
| Leonard S. Jacob | M | 75 |
Smithkline & French Laboratories US, Inc.
| 9 years |
| Robert G. L. Shorr | M | 71 |
Smithkline & French Laboratories US, Inc.
| 6 years |
| Douglas L. Cole | M | 77 | 13 years | |
| Arthur Levin | M | 70 | - | |
| Richard K. Brown | M | 71 | - | |
| Patricia Lowenstam | F | 77 | - | |
| Kleanthis Xanthopoulos | M | 66 | - | |
| Mark K. Wedel | M | 77 | 7 years | |
| Ronald C. Griffith | M | 76 | - | |
| Richard Bagley | M | 80 |
Smithkline & French Laboratories US, Inc.
| 17 years |
| Patrick Keran | M | 52 | 2 years | |
| James Cavanaugh | M | 87 |
Smithkline & French Laboratories US, Inc.
| 4 years |
| Sidney M. Hecht | M | 80 |
Smithkline & French Laboratories US, Inc.
| 6 years |
| Christopher F. O. Gabrieli | M | 64 | 17 years | |
| F. Andrew Dorr | M | - | 7 years | |
| William R. Shanahan | M | 74 | 6 years | |
| Jeff Jonas | M | 71 | 1 years | |
| Jason Ferrone | M | 50 | 11 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 62 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David J. Ecker
- Personal Network
